An early piece of research into the safety and tolerability of stem cell therapy called ReN001 for the treatment of ischaemic stroke (where blood supply to the brain is blocked by blood clots) suggests that the nine people included in the PISCES Trial experienced no adverse effects and showed a modest improvement in stroke-related symptoms.
This relates to University of Glasgow’s press release Encouraging data from stem cell trial in stroke patients as plans for Phase II progress. (May 27th 2013).
Stem cell stroke treatment trial results ‘show promise’. London: NHS Choices, May 28th 2013.
Ghosh, P (2013). Stroke patients see signs of recovery in stem-cell trial. London: BBC Health News, May 27th 2013.
[A brief reference to this item features in Dementia and Elderly Care: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 9, August 2013].